Display options
Cite
Dron JS, Hegele RA. Editorial: Discussing polygenic risk with lipid clinic patients. Curr Opin Lipidol. 2021;32(4):273-275doi: 10.1097/MOL.0000000000000768.
Dron, J. S., & Hegele, R. A. (2021). Editorial: Discussing polygenic risk with lipid clinic patients. Current opinion in lipidology, 32(4), 273-275. https://doi.org/10.1097/MOL.0000000000000768
Dron, Jacqueline S, and Hegele, Robert A. "Editorial: Discussing polygenic risk with lipid clinic patients." Current opinion in lipidology vol. 32,4 (2021): 273-275. doi: https://doi.org/10.1097/MOL.0000000000000768
Dron JS, Hegele RA. Editorial: Discussing polygenic risk with lipid clinic patients. Curr Opin Lipidol. 2021 Aug 01;32(4):273-275. doi: 10.1097/MOL.0000000000000768. PMID: 34054107.
Copy Download .nbib Format: NLM
Share it on

Curr Opin Lipidol. 2021 Aug 01;32(4):273-275. doi: 10.1097/MOL.0000000000000768.

Editorial: Discussing polygenic risk with lipid clinic patients.

Current opinion in lipidology

Jacqueline S Dron, Robert A Hegele

Affiliations

  1. Center for Genomic Medicine, Massachusetts General Hospital, Boston.
  2. Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  3. Robarts Research Institute and Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.

PMID: 34054107 DOI: 10.1097/MOL.0000000000000768

[No abstract available.]

References

  1. Wand H, Lambert SA, Tamburro C, et al. Improving reporting standards for polygenic scores in risk prediction studies. Nature 2021; 591:211–219. - PubMed
  2. Wand H, Knowles JW, Clarke SL. The need for polygenic score reporting standards in evidence-based practice: lipid genetics use case. Curr Opin Lipidol 2021; 32:89–95. - PubMed
  3. Brockman DG, Petronio L, Dron JS, et al. Design and user experience testing of a polygenic score report: a qualitative study of prospective users. medRxiv 2021. - PubMed
  4. Hegele RA, Dron JS. 2019 George Lyman Duff Memorial Lecture: three decades of examining DNA in patients with dyslipidemia. Arterioscler Thromb Vasc Biol 2020; 40:1970–1981. - PubMed
  5. Johansen CT, Dubé JB, Loyzer MN, et al. LipidSeq: a next-generation clinical resequencing panel for monogenic dyslipidemias. J Lipid Res 2014; 55:765–772. - PubMed
  6. Hegele RA, Ban MR, Cao H, et al. Targeted next-generation sequencing in monogenic dyslipidemias. Curr Opin Lipidol 2015; 26:103–113. - PubMed
  7. Dron JS, Wang J, McIntyre AD, et al. Six years’ experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias. BMC Med Genom 2020; 13:23. - PubMed
  8. Trinder M, Brunham LR. Polygenic scores for dyslipidemia: the emerging genomic model of plasma lipoprotein trait inheritance. Curr Opin Lipidol 2021; 32:103–111. - PubMed
  9. Cupido AJ, Tromp TR, Hovingh GK. The clinical applicability of polygenic risk scores for LDL-cholesterol: considerations, current evidence and future perspectives. Curr Opin Lipidol 2021; 32:112–116. - PubMed
  10. Christoffersen M, Tybjaerg-Hansen A. Polygenic risk scores – how much do they add? Curr Opin Lipidol 2021; 32:157–162. - PubMed
  11. Wang J, Dron JS, Ban MR, et al. Polygenic versus monogenic causes of hypercholesterolemia ascertained clinically. Arterioscler Thromb Vasc Biol 2016; 36:2439–2445. - PubMed
  12. Dron JS, Wang J, Cao H, et al. Severe hypertriglyceridemia is primarily polygenic. J Clin Lipidol 2019; 13:80–88. - PubMed
  13. Dron JS, Hegele RA. The evolution of genetic-based risk scores for lipids and cardiovascular disease. Curr Opin Lipidol 2019; 30:71–81. - PubMed
  14. Lazarte J, Hegele RA. Can genetic testing help in the management of dyslipidaemias? Curr Opin Lipidol 2020; 31:187–193. - PubMed
  15. Safarova MS, Kullo IJ. Using the electronic health record for genomics research. Curr Opin Lipidol 2020; 31:85–93. - PubMed

Publication Types

Grant support